14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response

DNA Repair

Volumn 8, Issue 9, 2009, Pages 1009-1017

  Mohammad, Duaa H ^a   Yaffe, Michael B ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

14 3 3; 53BP 1; BRCA1; BRCT domain; DNA damage response; FHA domain; MDC1; Phosphopeptide binding; RNF8

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; DNA; DNA DEPENDENT PROTEIN KINASE; PROTEIN 14 3 3; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; DNA DAMAGE; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; HUMAN; IONIZING RADIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY;

14-3-3 PROTEINS; ANIMALS; CELL CYCLE; CELL NUCLEUS; DNA DAMAGE; HUMANS; PROTEIN STRUCTURE, TERTIARY; RADIATION, IONIZING;

EID: 68249125947     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2009.04.004     Document Type: Article

References (99)

1. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15 (2001) 2177-2196
2. Chen J.S., Lin S.Y., Tso W.L., Yeh G.C., Lee W.S., Tseng H., Chen L.C., and Ho Y.S. Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis. Mol. Carcinog. 45 (2006) 461-478
3. Manke I.A., Nguyen A., Lim D., Stewart M.Q., Elia A.E., and Yaffe M.B. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell 17 (2005) 37-48
4. Reinhardt H.C., Aslanian A.S., Lees J.A., and Yaffe M.B. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 11 (2007) 175-189
5. Li J., Taylor I.A., Lloyd J., Clapperton J.A., Howell S., MacMillan D., and Smerdon S.J. Chk2 oligomerization studied by phosphopeptide ligation: implications for regulation and phosphodependent interactions. J. Biol. Chem. 283 (2008) 36019-36030
6. Yu X., Chini C.C., He M., Mer G., and Chen J. The BRCT domain is a phospho-protein binding domain. Science 302 (2003) 639-642
7. Rodriguez M., Yu X., Chen J., and Songyang Z. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. J. Biol. Chem. 278 (2003) 52914-52918
8. Clapperton J.A., Manke I.A., Lowery D.M., Ho T., Haire L.F., Yaffe M.B., and Smerdon S.J. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Nat. Struct. Mol. Biol. 11 (2004) 512-518
9. Stucki M., and Jackson S.P. MDC1/NFBD1: a key regulator of the DNA damage response in higher eukaryotes. DNA Repair (Amst.) 3 (2004) 953-957
10. Dalal S.N., Yaffe M.B., and DeCaprio J.A. 14-3-3 family members act coordinately to regulate mitotic progression. Cell Cycle 3 (2004) 672-677
11. Hermeking H., and Benzinger A. 14-3-3 proteins in cell cycle regulation. Semin. Cancer Biol. 16 (2006) 183-192
12. Kumagai A., Yakowec P.S., and Dunphy W.G. 14-3-3 proteins act as negative regulators of the mitotic inducer Cdc25 in Xenopus egg extracts. Mol. Biol. Cell 9 (1998) 345-354
13. Peng C.Y., Graves P.R., Thoma R.S., Wu Z., Shaw A.S., and Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277 (1997) 1501-1505
14. Wilker E.W., Grant R.A., Artim S.C., and Yaffe M.B. A structural basis for 14-3-3sigma functional specificity. J. Biol. Chem. 280 (2005) 18891-18898
15. Manke I.A., Lowery D.M., Nguyen A., and Yaffe M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302 (2003) 636-639
16. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., Gamblin S.J., Smerdon S.J., and Cantley L.C. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91 (1997) 961-971
17. Muslin A.J., Tanner J.W., Allen P.M., and Shaw A.S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84 (1996) 889-897
18. Gardino A.K., Smerdon S.J., and Yaffe M.B. Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms. Semin. Cancer Biol. 16 (2006) 173-182
19. Yaffe M.B. How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513 (2002) 53-57
20. Coblitz B., Shikano S., Wu M., Gabelli S.B., Cockrell L.M., Spieker M., Hanyu Y., Fu H., Amzel L.M., and Li M. C-terminal recognition by 14-3-3 proteins for surface expression of membrane receptors. J. Biol. Chem. 280 (2005) 36263-36272
21. Waterman M.J., Stavridi E.S., Waterman J.L., and Halazonetis T.D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19 (1998) 175-178
22. Graves P.R., Lovly C.M., Uy G.L., and Piwnica-Worms H. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene 20 (2001) 1839-1851
23. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., and Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
24. Mils V., Baldin V., Goubin F., Pinta I., Papin C., Waye M., Eychene A., and Ducommun B. Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. Oncogene 19 (2000) 1257-1265
25. Honda R., Ohba Y., and Yasuda H. 14-3-3 zeta protein binds to the carboxyl half of mouse wee1 kinase. Biochem. Biophys. Res. Commun. 230 (1997) 262-265
26. Lee J., Kumagai A., and Dunphy W.G. Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol. Biol. Cell 12 (2001) 551-563
27. Rothblum-Oviatt C.J., Ryan C.E., and Piwnica-Worms H. 14-3-3 binding regulates catalytic activity of human Wee1 kinase. Cell Growth Differ. 12 (2001) 581-589
28. Raleigh J.M., and O'Connell M.J. The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. J. Cell Sci. 113 Pt 10 (2000) 1727-1736
29. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S., Kinzler K.W., and Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1 (1997) 3-11
30. Laronga C., Yang H.Y., Neal C., and Lee M.H. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J. Biol. Chem. 275 (2000) 23106-23112
31. Wilker E.W., van Vugt M.A., Artim S.A., Huang P.H., Petersen C.P., Reinhardt H.C., Feng Y., Sharp P.A., Sonenberg N., White F.M., and Yaffe M.B. 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature 446 (2007) 329-332
32. Fujita N., Sato S., Katayama K., and Tsuruo T. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 277 (2002) 28706-28713
33. Sekimoto T., Fukumoto M., and Yoneda Y. 14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1). EMBO J. 23 (2004) 1934-1942
34. Gong W., Russell M., Suzuki K., and Riabowol K. Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression. Mol. Cell Biol. 26 (2006) 2947-2954
35. Fukuhara N., Ebert J., Unterholzner L., Lindner D., Izaurralde E., and Conti E. SMG7 is a 14-3-3-like adaptor in the nonsense-mediated mRNA decay pathway. Mol. Cell 17 (2005) 537-547
36. Durocher D., Henckel J., Fersht A.R., and Jackson S.P. The FHA domain is a modular phosphopeptide recognition motif. Mol. Cell 4 (1999) 387-394
37. Liao H., Yuan C., Su M.I., Yongkiettrakul S., Qin D., Li H., Byeon I.J., Pei D., and Tsai M.D. Structure of the FHA1 domain of yeast Rad53 and identification of binding sites for both FHA1 and its target protein Rad9. J. Mol. Biol. 304 (2000) 941-951
38. Li J., Williams B.L., Haire L.F., Goldberg M., Wilker E., Durocher D., Yaffe M.B., Jackson S.P., and Smerdon S.J. Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2. Mol. Cell 9 (2002) 1045-1054
39. Hofmann K., and Bucher P. The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors. Trends Biochem. Sci. 20 (1995) 347-349
40. Callebaut I., and Mornon J.P. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400 (1997) 25-30
41. Bork P., Hofmann K., Bucher P., Neuwald A.F., Altschul S.F., and Koonin E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11 (1997) 68-76
42. Stucki M., Clapperton J.A., Mohammad D., Yaffe M.B., Smerdon S.J., and Jackson S.P. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123 (2005) 1213-1226
43. Shiozaki E.N., Gu L., Yan N., and Shi Y. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling. Mol. Cell 14 (2004) 405-412
44. Castilla L.H., Couch F.J., Erdos M.R., Hoskins K.F., Calzone K., Garber J.E., Boyd J., Lubin M.B., Deshano M.L., Brody L.C., et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat. Genet. 8 (1994) 387-391
45. Sun Y., Xu Y., Roy K., and Price B.D. DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity. Mol. Cell Biol. 27 (2007) 8502-8509
46. Sun Y., Jiang X., Chen S., Fernandes N., and Price B.D. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13182-13187
47. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
48. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., and Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273 (1998) 5858-5868
49. Fernandez-Capetillo O., Lee A., Nussenzweig M., and Nussenzweig A. H2AX: the histone guardian of the genome. DNA Repair (Amst.) 3 (2004) 959-967
50. Goldberg M., Stucki M., Falck J., D'Amours D., Rahman D., Pappin D., Bartek J., and Jackson S.P. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature 421 (2003) 952-956
51. Lou Z., Minter-Dykhouse K., Wu X., and Chen J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature 421 (2003) 957-961
52. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., and Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421 (2003) 961-966
53. Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J., Lukas C., and Lukas J. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131 (2007) 887-900
54. Xu X., and Stern D.F. NFBD1/MDC1 regulates ionizing radiation-induced focus formation by DNA checkpoint signaling and repair factors. FASEB J. 17 (2003) 1842-1848
55. Bekker-Jensen S., Lukas C., Melander F., Bartek J., and Lukas J. Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1. J. Cell Biol. 170 (2005) 201-211
56. Huen M.S., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., and Chen J. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 131 (2007) 901-914
57. Wang B., and Elledge S.J. Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 20759-20763
58. Burma S., Chen B.P., Murphy M., Kurimasa A., and Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276 (2001) 42462-42467
59. Fernandez-Capetillo O., Chen H.T., Celeste A., Ward I., Romanienko P.J., Morales J.C., Naka K., Xia Z., Camerini-Otero R.D., Motoyama N., Carpenter P.B., Bonner W.M., Chen J., and Nussenzweig A. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat. Cell. Biol. 4 (2002) 993-997
60. Rogakou E.P., Boon C., Redon C., and Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell. Biol. 146 (1999) 905-916
61. Chapman J.R., and Jackson S.P. Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO Rep. 9 (2008) 795-801
62. Melander F., Bekker-Jensen S., Falck J., Bartek J., Mailand N., and Lukas J. Phosphorylation of SDT repeats in the MDC1 N terminus triggers retention of NBS1 at the DNA damage-modified chromatin. J. Cell. Biol. 181 (2008) 213-226
63. Spycher C., Miller E.S., Townsend K., Pavic L., Morrice N.A., Janscak P., Stewart G.S., and Stucki M. Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin. J. Cell. Biol. 181 (2008) 227-240
64. Wu L., Luo K., Lou Z., and Chen J. MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 11200-11205
65. Lee M.S., Edwards R.A., Thede G.L., and Glover J.N. Structure of the BRCT repeat domain of MDC1 and its specificity for the free COOH-terminal end of the gamma-H2AX histone tail. J. Biol. Chem. 280 (2005) 32053-32056
66. Becker E., Meyer V., Madaoui H., and Guerois R. Detection of a tandem BRCT in Nbs1 and Xrs2 with functional implications in the DNA damage response. Bioinformatics 22 (2006) 1289-1292
67. Xu C., Wu L., Cui G., Botuyan M.V., Chen J., and Mer G. Structure of a second BRCT domain identified in the nijmegen breakage syndrome protein Nbs1 and its function in an MDC1-dependent localization of Nbs1 to DNA damage sites. J. Mol. Biol. 381 (2008) 361-372
68. Kobayashi J., Tauchi H., Sakamoto S., Nakamura A., Morishima K., Matsuura S., Kobayashi T., Tamai K., Tanimoto K., and Komatsu K. NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain. Curr. Biol. 12 (2002) 1846-1851
69. Kolas N.K., Chapman J.R., Nakada S., Ylanko J., Chahwan R., Sweeney F.D., Panier S., Mendez M., Wildenhain J., Thomson T.M., Pelletier L., Jackson S.P., and Durocher D. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 318 (2007) 1637-1640
70. Kim H., Chen J., and Yu X. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 316 (2007) 1202-1205
71. Kim H., Huang J., and Chen J. CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response. Nat. Struct. Mol. Biol. 14 (2007) 710-715
72. Wang B., Matsuoka S., Ballif B.A., Zhang D., Smogorzewska A., Gygi S.P., and Elledge S.J. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316 (2007) 1194-1198
73. Sobhian B., Shao G., Lilli D.R., Culhane A.C., Moreau L.A., Xia B., Livingston D.M., and Greenberg R.A. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316 (2007) 1198-1202
74. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., 3rd K.E., Hurov J., Luo C.E., Bakalarski Z., Zhao N., Solimini Y., Lerenthal Y., Shiloh S.P., Gygi S.J., and Elledge. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316 (2007) 1160-1166
75. Wood J.L., Singh N., Mer G., and Chen J. MCPH1 functions in an H2AX-dependent but MDC1-independent pathway in response to DNA damage. J. Biol. Chem. 282 (2007) 35416-35423
76. Lin S.Y., Rai R., Li K., Xu Z.X., and Elledge S.J. BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 15105-15109
77. Yang S.Z., Lin F.T., and Lin W.C. MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis. EMBO Rep. 9 (2008) 907-915
78. Xu X., Lee J., and Stern D.F. Microcephalin is a DNA damage response protein involved in regulation of CHK1 and BRCA1. J. Biol. Chem. 279 (2004) 34091-34094
79. Jeffers L.J., Coull B.J., Stack S.J., and Morrison C.G. Distinct BRCT domains in Mcph1/Brit1 mediate ionizing radiation-induced focus formation and centrosomal localization. Oncogene 27 (2008) 139-144
80. Wood J.L., Liang Y., Li K., and Chen J. Microcephalin/MCPH1 associates with the Condensin II complex to function in homologous recombination repair. J. Biol. Chem. 283 (2008) 29586-29592
81. Cho E.A., Prindle M.J., and Dressler G.R. BRCT domain-containing protein PTIP is essential for progression through mitosis. Mol. Cell. Biol. 23 (2003) 1666-1673
82. Jowsey P.A., Doherty A.J., and Rouse J. Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation. J. Biol. Chem. 279 (2004) 55562-55569
83. Gong Z., Cho Y.W., Kim J.E., Ge K., and Chen J. Accumulation of Pax2 transactivation-domain interaction protein (PTIP) to sites of DNA breaks via RNF8-dependent pathway is required for cell survival following DNA damage. J. Biol. Chem. (2009)
84. Munoz I.M., Jowsey P.A., Toth R., and Rouse J. Phospho-epitope binding by the BRCT domains of hPTIP controls multiple aspects of the cellular response to DNA damage. Nucleic Acids Res. 35 (2007) 5312-5322
85. Cho Y.W., Hong T., Hong S., Guo H., Yu H., Kim D., Guszczynski T., Dressler G.R., Copeland T.D., Kalkum M., and Ge K. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J. Biol. Chem. 282 (2007) 20395-20406
86. Bartek J., and Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3 (2003) 421-429
87. Reinhardt H.C., and Yaffe M.B. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr. Opin. Cell. Biol. (2009)
88. Ahn J., and Prives C. Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylation. J. Biol. Chem. 277 (2002) 48418-48426
89. Ahn J.Y., Li X., Davis H.L., and Canman C.E. Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain. J. Biol. Chem. 277 (2002) 19389-19395
90. Schwarz J.K., Lovly C.M., and Piwnica-Worms H. Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation. Mol. Cancer Res. 1 (2003) 598-609
91. Oliver A.W., Paul A., Boxall K.J., Barrie S.E., Aherne G.W., Garrett M.D., Mittnacht S., and Pearl L.H. Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange. EMBO J. 25 (2006) 3179-3190
92. Bell D.W., Varley J.M., Szydlo T.E., Kang D.H., Wahrer D.C., Shannon K.E., Lubratovich M., Verselis S.J., Isselbacher K.J., Fraumeni J.F., Birch J.M., Li F.P., Garber J.E., and Haber D.A. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286 (1999) 2528-2531
93. Xu X., Tsvetkov L.M., and Stern D.F. Chk2 activation and phosphorylation-dependent oligomerization. Mol. Cell. Biol. 22 (2002) 4419-4432
94. Liu F., Stanton J.J., Wu Z., and Piwnica-Worms H. The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol. Cell. Biol. 17 (1997) 571-583
95. Parker L.L., and Piwnica-Worms H. Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 257 (1992) 1955-1957
96. Forrest A., and Gabrielli B. Cdc25B activity is regulated by 14-3-3. Oncogene 20 (2001) 4393-4401
97. Giles N., Forrest A., and Gabrielli B. 14-3-3 acts as an intramolecular bridge to regulate cdc25B localization and activity. J. Biol. Chem. 278 (2003) 28580-28587
98. Kumagai A., and Dunphy W.G. Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev. 13 (1999) 1067-1072
99. Rajagopalan S., Jaulent A.M., Wells M., Veprintsev D.B., and Fersht A.R. 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers. Nucleic Acids Res. 36 (2008) 5983-5991